Products
3579 products
Page:1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36
| Code | Description | Unit |
|---|---|---|
| USP-1445481 | Monensin Sodium | 200 mg |
| USP-1445492 | Monk Fruit Extract | 500 mg |
| USP-1445506 | Monobenzone | 200 mg |
| USP-1445608 | Moexipril Related Compound A | 20 mg |
| USP-1445619 | Moexipril Related Compound B - ((S)-ethyl 2-{(3S,11aS)-8,9-dimethoxy-3-methyl-1,4-dioxo-3,4-dihydro-1H | 20 mg |
| USP-1445631 | Moexipril Related Compound D - ((S)-2-{(S)-2-[(S)-4-cyclohexyl-1-ethoxy-1-oxobutan-2-ylamino]propanoyl | 20 mg |
| USP-1445642 | Moexipril Related Compound E - ((S)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid, hy | 20 mg |
| USP-1445653 | Moexipril Related Compound F | 20 mg |
| USP-1445664 | Moexipril Related Compound G - ((S)-6,7-dimethoxy-2-{(S)-2-[(S)-1-methoxy-1-oxo-4-phenylbutan-2-ylamino]propanoyl}-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid, hydrochloride) | 20 mg |
| USP-1445925 | Monoethanolamine | 1 mL |
| USP-1446000 | Monoglycerides | 125 mg |
| USP-1446600 | Monosodium Glutamate | 1 g |
| USP-1446804 | Monostearyl Maleate | 100 mg |
| USP-1446815 | Montelukast Dicyclohexylamine | 150 mg |
| USP-1446837 | Montelukast for Peak Identification | 20 mg |
| USP-1446848 | Montelukast Racemate | 20 mg |
| USP-1446859 | Montelukast Sodium | 50 mg |
| USP-1446906 | Morantel Tartrate | 100 mg |
| USP-1446950 | Moricizine Hydrochloride (HCl) | 250 mg |
| USP-1448027 | Morphine Sulfate Related Compound B - Pseudomorphine CII (controlled substance in USA) | 20 mg |
| USP-1448560 | Moxidectin System Suitability Mixture | 50 mg |
| USP-1448606 | Moxifloxacin Hydrochloride (HCl) | 200 mg |
| USP-1448617 | Moxifloxacin Related Compound A - 1-cyclopropyl-6,8-difluoro-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-1,4-dihydroquinoline-3-carboxylic acid | 25 mg |
| USP-1448901 | Mupirocin | 50 mg |
| USP-1448912 | Mupirocin Calcium | 200 mg |
| USP-1448923 | Mupirocin Lithium | 100 mg |
| USP-1448956 | Mycophenolate Mofetil | 200 mg |
| USP-1448967 | Mycophenolate Mofetil Related Compound A - 2-morpholinoethyl-(E)-6-(1,3-dihydro-4,6-dihydroxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-4-hexenoate | 15 mg |
| USP-1448978 | Mycophenolate Mofetil Related Compound B - [(RS)-7-hydroxy-5-methoxy-4-methyl-6-[2-(5-methyl-2-oxo-tetrahydrofuran-5-yl)ethyl]-3H-isobenzofuranyl-1-one] | 15 mg |
| USP-1448990 | Myristic Acid | 200 mg |
| USP-1449008 | Myristyl Alcohol | 1 g |
| USP-1449518 | Nabumetone | 200 mg |
| USP-1449530 | Nabumetone Related Compound A - 1-(6-methoxy-2-naphthyl)-but-1-en-3-one | 15 mg |
| USP-1449700 | Nadolol | 200 mg |
| USP-1450007 | Nafcillin Sodium | 200 mg |
| USP-1450404 | Naftifine Hydrochloride (HCl) | 200 mg |
| USP-1451000 | Nalidixic Acid | 200 mg |
| USP-1452002 | Nalorphine Hydrochloride (HCl) CIII (controlled substance in USA) | 250 mg |
| USP-1453005 | Naloxone | 125 mg |
| USP-1453504 | Naltrexone | 200 mg |
| USP-1453526 | Naltrexone Related Compound A - CII N-(3-butenyl)-noroxymorphone Hydrochloride (HCl) (controlled substance in USA) | 30 mg |
| USP-1454008 | Nandrolone CIII (controlled substance in USA) | 50 mg |
| USP-1455000 | Nandrolone Decanoate CIII (controlled substance in USA) (COLD SHIPMENT REQUIRED) | 250 mg |
| USP-1456003 | Nandrolone Phenpropionate CIII (controlled substance in USA) | 250 mg |
| USP-1457006 | Naphazoline Hydrochloride (HCl) | 200 mg |
| USP-1457083 | Naphthalene | 200 mg |
| USP-1457301 | Naproxen | 200 mg |
| USP-1457403 | Naproxen Sodium | 200 mg |
| USP-1457458 | Narasin | 125 mg |
| USP-1457469 | Naratriptan Hydrochloride (HCl) | 125 mg |
| USP-1457491 | Naratriptan Resolution Mixture | 20 mg |
| USP-1457505 | Natamycin | 200 mg |
| USP-1457607 | Nateglinide | 200 mg |
| USP-1457618 | Nateglinide Related Compound A - trans-4-isopropylcyclohexanecarboxylic acid | 10 mg |
| USP-1457629 | Nateglinide Related Compound B - N-(trans-4-isopropylcyclohexanecarbonyl)-L-phenylalanine | 10 mg |
| USP-1457630 | Nateglinide Related Compound C - N-(cis-4-isopropylcyclohexanecarbonyl)-D-phenylalanine | 5 mg |
| USP-1457844 | Near IR System Suitability | unit |
| USP-1457902 | Nefazodone Hydrochloride (HCl) | 200 mg |
| USP-1457913 | Nefazodone Related Compound A - 1-(3-chlorophenyl)-4-(3-chloropropyl)-piperazine hydrochloride | 25 mg |
| USP-1457924 | Nefazodone Related Compound B - 2-[3-[4-(4-chlorophenyl)-1-piperazinyl]propyl]-5-ethyl-2,4-dihydro-4-(2-phenoxyethyl)-3H-1,2,4-triazol-3-one hydrochloride | 25 mg |
| USP-1457968 | This item has been discontinued - Nelfinavir Mesylate | 200 mg |
| USP-1457979 | Nelfinavir Related Compound A - (3S,4aS,8aS)-N-tert-Butyl-2-[(2R,3R)-2-hydroxy-3-(3-hydroxy-2-methylbenzamido)-4-(phenylsulfinyl)butyl]decahydroisoquinoline-2-carboxymide | 15 mg |
| USP-1458009 | Neomycin Sulfate | 200 mg |
| USP-1458053 | Neohesperidine Dihydrochalcone | 100 mg |
| USP-1459001 | Neostigmine Bromide | 200 mg |
| USP-1460000 | Neostigmine Methylsulfate | 200 mg |
| USP-1460204 | Neotame | 200 mg |
| USP-1460215 | Neotame Related Compound A - N-[N-(3-3-dimethylbutyl)-L-alpha-aspartyl]-L-phenylalanine | 15 mg |
| USP-1460500 | Netilmicin Sulfate | 500 mg |
| USP-1460703 | Nevirapine Anhydrous | 100 mg |
| USP-1460714 | Nevirapine Hemihydrate | 100 mg |
| USP-1460725 | Nevirapine Related Compound A - 5,11-Dihydro-4-methyl-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one | 15 mg |
| USP-1460736 | Nevirapine Related Compound B - 5,11-Dihydro-4-methyl-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one | 15 mg |
| USP-1461003 | Niacin | 200 mg |
| USP-1462006 | Niacinamide (Vitamin B3) | 500 mg |
| USP-1463224 | Nicardipine Hydrochloride | 200 mg |
| USP-1463304 | Nicotine Bitartrate Dihydrate | 500 mg |
| USP-1463508 | Nifedipine | 125 mg |
| USP-1463600 | Nifedipine Nitrophenylpyridine Analog | 25 mg |
| USP-1463701 | Nifedipine Nitrosophenylpyridine Analog | 25 mg |
| USP-1463858 | Nimodipine | 125 mg |
| USP-1463869 | Nimodipine Related Compound B - bis(2-methoxyethyl) 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate (AS) | 50 mg |
| USP-1463870 | Nimodipine Related Compound A - 2-methoxyethyl-1-methylethyl-2,6-dimethyl-4-(3-nitrophenyl)pyridine-3,5-dicarboxylate | 50 mg |
| USP-1463950 | Nitrilotriacetic Acid | 50 mg |
| USP-1463960 | Nitazoxanide | 200 mg |
| USP-1463971 | Niltazoxanide Related Compound A - 2-Amino-5-nitrothiazole | 25 mg |
| USP-1464001 | Nitrofurantoin | 500 mg |
| USP-1465004 | Nitrofurazone | 200 mg |
| USP-1465503 | Nitrofurfural Diacetate | 100 mg |
| USP-1466007 | Nitrofurazone Related Compound A - 5-Nitro-2-furfuraldazine | 500 mg |
| USP-1466506 | Diluted Nitroglycerin (5 ampules, approx. 200 mg of a 0,948% solution in propylene glycol each) (additional transportation cost) (COLD SHIPMENT REQUIRED) | 5 ampoules |
| USP-1467804 | Nizatidine | 200 mg |
| USP-1467950 | Nonoxynol 9 | 0,5 mL |
| USP-1468002 | Nonoxynol 10 | 200 mg |
| USP-1468501 | Norepinephrine Bitartrate | 125 mg |
| USP-1469005 | Norethindrone | 200 mg |
| USP-1470004 | Norethindrone Acetate | 100 mg |
| USP-1471506 | Norfloxacin | 200 mg |
| USP-1471914 | Norgestimate | 200 mg |
| USP-1471925 | Norgestimate Related Compound A - Levonorgestrel Acetate | 25 mg |